22 February 2021
Visiongain has published a new report on Parenteral Nutrition Market Report 2021-2031: Forecasts By Nutrition Type (Carbohydrates, Parenteral Lipid Emulsions, Single Dose Amino Acid Solutions, Trace Elements, Electrolytes, & Minerals, Vitamins, and Others), By Type (Generic, and Branded), Patient Demographics (Adults, Geriatric, and Pediatric), By End User (Hospitals, Homecare, Specialty Clinics, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), PLUS Profiles of Leading Manufacturing Companies and Regional and Leading National Market Analysis. PLUS COVID-19 Recovery Scenarios.
Global Parenteral Nutrition market was valued at US$ xx Million in 2020 and is projected to reach at a market value of US$ xx Million by 2031. North America dominated the global Parenteral Nutrition market and is projected to witness CAGR of XX% during the first half of the forecast period i.e. 2021 to 2031.
COVID-19 Impact on Parenteral Nutrition Market
COVID-19 impact through different recovery models such as V-shaped, U-shaped, W-shaped, and L-shaped; has been taken into consideration while estimating and forecasting the Parenteral Nutrition market. Different recovery scenarios are also included in the report for all the segments and regions/nation. The recovery scenarios based on which market has been forecasted and analysed herein the report are mentioned below:
Increasing Prevalence of Chronic Diseases around the World
The burden of chronic diseases is increasing very rapidly around the world. Prevalence of chronic diseases it is expected to continuously rising over the forecast period due to rapid change in life style (consumption of alcohol, tobacco and among other) and increasing consumption of malnutrition’s in day to day life. The increasing prevalence is chronic diseases is creating a huge demand for the parenteral nutrition. Due to which increasing prevalence of chronic diseases around the world is working as a driver for the parenteral nutrition market.
Increasing Therapeutic Advancements in Parenteral Nutrition
Increasing prevalence of chronic diseases has led various leading manufactures to increase their research and development activities for parenteral nutrition. Research and development activities for new technological advanced parenteral nutrition are helping to increase adoption of novel therapeutic in parenteral nutrition. Currently, many of the manufacturers are launching their product portfolios in parenteral nutrition which is expected to fulfil demand and to work as a driver for the market. Therapeutic advancements in the parenteral nutrition especially help to increase demand of parenteral nutrition. Currently, many of the manufacturers are engaged in research and development activities creating competitive advantages with the launch of their new products in the market.
Growing Awareness Regarding Consumption of Parenteral Nutrition
Governments in various developed and developing nations are increasing their initiatives to increase awareness regarding life threatening disease and preventive measures to increase the immune system with the help of various nutrition. Further, Governments and private authority across the developed & developing countries are focusing on regulatory approvals for various new parenteral nutrition applications to increase availability of parenteral nutrition products in order to remove monopolies and to create an ideal market scenario.
Top companies (B. Braun Melsungen AG, Fresenius Kabi AG, and ALLERGAN) constitute more than XX% share of the global Parenteral Nutrition market. Other companies profiled in the report include: Grifols, S.A., Pfizer Inc., Otsuka Pharmaceutical Factory, Inc., Baxter, Vifor Pharma, Aculife, Grifols, S.A. others Some of the key developments are listed below:
● In 2020, BIOSALMA has launched Omega-3 Pure and Natural product, which is fully certified to both MSC and ASC standards. The product is World’s First MSC and ASC Certified Omega-3 Supplements. The launch will help the company widen revenue generation from a market focused product portfolio.
● In 2019, Baxter International Inc. launched Olimel N12, which is an olive oil-based parenteral nutrition (PN) triple-chamber bag portfolio. The launch will help the company to increase revenue generation in the Parenteral Nutrition market.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to email@example.com or call her on +44 (0) 20 7549 9987.
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
The global stem cell technologies and applications market was valued at US$9,247 million in 2021 and is projected to grow at a CAGR of 8.9% during the forecast period 2022-2032.
01 December 2022
The biosimilars and follow-on biologics market is valued at US$19,668.3 million in 2022 and is projected to grow at a CAGR of 31.14% during the forecast period 2023-2033.
01 December 2022
The Medical Imaging market was valued at US$38.6 billion in 2021 and is projected to grow at a CAGR of 5.46% during the forecast period 2022-2032.
30 November 2022
The global antibody drug conjugates market was valued at US$3,668 million in 2021 and is projected to grow at a CAGR of 15.1% during the forecast period 2022-2032.